Company Intercept Pharmaceuticals, Inc.
Equities
ICPT
US45845P1084
Biotechnology & Medical Research
Business Summary
Number of employees: 341
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 17-02-22 |
Andrew Saik
DFI | Director of Finance/CFO | 54 | 21-06-20 |
M. Berrey
CTO | Chief Tech/Sci/R&D Officer | 57 | 21-06-08 |
Jose Truzman
SEC | Corporate Secretary | - | - |
Rocco Venezia
AUD | Comptroller/Controller/Auditor | 48 | 15-12-31 |
General Counsel | 55 | 21-01-10 | |
Corporate Officer/Principal | 60 | 17-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jerome B. Durso
CEO | Chief Executive Officer | 56 | 17-02-22 |
Director/Board Member | 55 | Nov. 07 | |
Stefano Pasi
BRD | Director/Board Member | - | Nov. 07 |
Michele Cera
BRD | Director/Board Member | - | Nov. 07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,825,966 | 40,940,614 ( 97.88 %) | 0 | 97.88 % |
Company contact information
Intercept Pharmaceuticals, Inc.
305 Madison Avenue
07960, Morristown
+646 747 1000
http://www.interceptpharma.comSector
1st Jan change | Capi. | |
---|---|---|
+19.33% | 125B | |
+13.95% | 109B | |
-3.53% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.62% | 16.64B | |
+0.99% | 13.45B | |
+21.79% | 11.32B |